ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Integrated network pharmacology analysis and in vitro validation revealed the underlying mechanism of Xiyanping injection in treating coronavirus disease 2019

Li, Jialin; Guo, Siyu; Tan, Yingying; Zhang, Jingyuan; Wu, Zhishan; Stalin, Antony; Zhang, Fanqin; Huang, Zhihong; Wu, Chao; Liu, Xinkui; Huang, Jiaqi; Wu, Jiarui*电子科技大学; 哈尔滨医科大学
Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries2023-8-25DOI: 10.1097/MD.0000000000034866
16阅读
引用收藏
分享

摘要

Background: Coronavirus disease 2019 (COVID-19) has spread rapidly worldwide, leading to a pandemic. In China, Xiyanping injection (XYP) has been recommended as a drug for COVID-19 treatment in the Guideline on Diagnosis and Treatment of COVID-19 by the National Health Commission of the People Republic of China and National Administration of Traditional Chinese Medicine (Trial eighth Edition). However, the relevant mechanisms at the molecular-level need to be further elucidated. @@@ Methods: In this study, XYP related active ingredients, potential targets and COVID-19 related genes were searched in public databases. Protein-protein interaction network and module analyzes were used to screen for key targets. gene ontology and Kyoto encyclopedia of genes and genomes were performed to investigate the potentially relevant signaling pathways. Molecular docking was performed using Autodock Tools and Vina. For the validation of potential mechanism, PolyI:C was used to induce human lung epithelial cells for an inflammation model. Subsequently, CCK-8 assays, enzyme-linked immunosorbent assay, reverse transcription quantitative polymerase chain reaction and western blot were employed to determine the effect of XYP on the expression of key genes. @@@ Results: Seven effective active ingredients in XYP were searched for 123 targets in the relevant databases. Furthermore, 6446 COVID-19 disease targets were identified. Sodium 9-dehydro-17-hydro-andrographolide-19-yl sulfate was identified as the vital active compounds, and IL-6, TNF, IL-1 beta, CXCL8, STAT3, MAPK1, MAPK14, and MAPK8 were considered as the key targets. In addition, molecular docking revealed that the active compound and the targets showed good binding affinities. The enrichment analysis predicted that the XYP could regulate the IL-17, Toll-like receptor, PI3K-Akt and JAK-STAT signaling pathways. Consistently, further in vitro experiments demonstrated that XYP could slow down the cytokine storm in the lung tissue of COVID-19 patients by down-regulating IL-6, TNF-alpha, IL-1 beta, CXCL8, and p-STAT3. @@@ Conclusion: Through effective network pharmacology analysis and molecular docking, this study suggests that XYP contains many effective compounds that may target COVID-19 related signaling pathways. Moreover, the in vitro experiment confirmed that XYP could inhibit the cytokine storm by regulating genes or proteins related to immune and inflammatory responses.

学科与关键词

关键词
coronavirus disease 2019in vitro validationmolecular dockingnetwork pharmacologyXiyanping injection
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries
发表日期
2023-08-25
卷期
第 102 卷, 第 34 期
页码
e34866
DOI
10.1097/MD.0000000000034866
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82074284]; China National Traditional Chinese Medicine Inheritance and Innovation Team Sub-project [ZYYCXTD-C-202005-10]; China Medical Association of Minorities Research Project [2020MZ298-110101]; Open Fund Project, Associated Key Laboratory of Traditional Mongolia Medicine Research and Development, National Ethnic Affairs Commission and Ministry of Education of China [MDK2020013]

作者

  • L

    Li, Jialin (第一作者)

    beijing univ chinese med · harbin med univ

  • G

    Guo, Siyu

    beijing univ chinese med

查看全部 12 位作者收起作者
  • T

    Tan, Yingying

    beijing univ chinese med

  • Z

    Zhang, Jingyuan

    beijing univ chinese med

  • W

    Wu, Zhishan

    beijing univ chinese med

  • S

    Stalin, Antony

    univ elect sci & technol china

  • Z

    Zhang, Fanqin

    beijing univ chinese med

  • H

    Huang, Zhihong

    beijing univ chinese med

  • W

    Wu, Chao

    beijing univ chinese med

  • L

    Liu, Xinkui

    beijing univ chinese med

  • H

    Huang, Jiaqi

    beijing univ chinese med

  • W

    Wu, Jiarui (通讯)

    beijing univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417